LEO Pharma in the UK

Geraldine Murphy, Managing Director LEO Pharma UK/IE introduces the organisation.


At LEO Pharma UK/Ireland (UK/IE), we aim to lead the way in establishing patient support programmes and joint working initiatives in our specialist areas. We also carry out clinical studies globally on behalf of the LEO Pharma group.

We’re truly passionate about driving innovation. Like the rest of our global company, LEO Pharma UK/IE is ultimately owned by the LEO Foundation. With no shareholders, we can invest more in research and development and advancing care for people who need it most.

At LEO Pharma UK/IE, we aim to lead the way in driving patient-focused and partnership approach to our activities. Our patient focused approach, combined with a distinct business model driven by our independent LEO Foundation ownership and knowledge of the UK and Irish markets make us a truly unique company. 

Coupled with this, our combination of innovative thinking and integrity also explains why LEO Pharma was the second company globally to declare its commitment to clinical data transparency in 2013. We continue to champion and drive leadership in this area in the UK.

Read about our Corporate social responsibility.

Cookies on this site

LEO Laboratories Limited uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our Cookie Policy. By browsing our sites, you consent to the use of cookies. If you want to know more about our cookie policy and how to avoid and delete cookies click here. By continuing to browse this site, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.